Company profile: Arthrosi Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology drug discovery and development, focused on AR882, a uricosuric therapy in development for gout to lower serum urate levels, reduce flares, and resolve tophi, with efficacy and safety demonstrated in clinical trials.
Products and services
- AR882: A uricosuric, clinical-trial-validated drug under development for gout, engineered to lower serum urate, reduce flares, and resolve tophi with demonstrated efficacy and safety
- Drug Development: Biotechnology-focused, Arthrosi Therapeutics concentrates on drug development, progressing under-development therapeutics into clinical trials to demonstrate efficacy and safety
- Industrial-grade
- Drug Discovery: Biotechnology-focused, Arthrosi Therapeutics focuses on drug discovery, architecting the earliest stages of therapeutics identification
- Research-grade.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Arthrosi Therapeutics
DermLite
HQ: United States
Website
- Description: Provider of hand-built dermoscopy tools and services, manufacturing and marketing pocket and photo dermatoscopes, Lumio skin scopes, phone adapters, accessories, and head-mounted vision. Products include DL5 and DL4 handheld dermatoscopes, DL200 Hybrid pocket dermatoscope, Lumio 2 skin scope, and connection kits for iPhone and mobile devices for digital dermoscopy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DermLite company profile →
Freenome
HQ: United States
Website
- Description: Provider of blood-based tests and clinical studies for early cancer detection to improve access to routine screening, including PREEMPT CRC for colorectal cancer and the PROACT LUNG study using a blood test. Runs the Vallania and Sanderson studies targeting multiple cancers, pairing real-world data with multiomics; partners with Walgreens to increase research diversity; and acquired Oncimmune Ltd to enhance its cancer detection portfolio.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Freenome company profile →
Barinthus Bio
HQ: United Kingdom
Website
- Description: Provider of clinical-stage immunotherapeutics and vaccines for infectious diseases and cancer, leveraging proprietary ChAdOx1/ChAdOx2 adenoviral vectors and MVA platforms to prime disease-specific T cells. Pipeline includes VTP-300 for chronic Hepatitis B, VTP-850 for prostate cancer, VTP-1000 for celiac disease, and the SNAP-TI platform to promote immune tolerance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Barinthus Bio company profile →
Medivation
HQ: United States
Website
- Description: Provider of biopharmaceutical R&D focused on rapid development of small‑molecule drugs to treat serious diseases with limited treatment options, including the development of MDV3100 for multiple stages of advanced prostate cancer in collaboration with Astellas Pharma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medivation company profile →
Epigenomics
HQ: Germany
Website
- Description: Provider of molecular diagnostics, developing and commercializing in vitro cancer diagnostic tests to detect cancer at early stages using body fluids such as blood plasma; offerings include Epi proColon, a blood test for colorectal cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epigenomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Arthrosi Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Arthrosi Therapeutics
2.2 - Growth funds investing in similar companies to Arthrosi Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Arthrosi Therapeutics
4.2 - Public trading comparable groups for Arthrosi Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →